申请人:Vertex Pharmaceuticals Incorporated
公开号:US20160152614A1
公开(公告)日:2016-06-02
Methods of inhibiting the replication of influenza viruses in a biological sample or patient, of reducing the amount of influenza viruses in a biological sample or patient, and of treating influenza in a patient, comprises administering to said biological sample or patient an effective amount of a compound represented by Structural Formula (I):
or a pharmaceutically acceptable salt thereof, wherein the values of Structural Formula (IA) are as described herein. A compound is represented by Structural Formula (IA) or a pharmaceutically acceptable salt thereof, wherein the values of Structural Formula (IA) are as described herein. A pharmaceutical composition comprises an effective amount of such a compound or pharmaceutically acceptable salt thereof, and a pharmaceutically acceptable carrier, adjuvant or vehicle.
抑制生物样本或患者中流感病毒复制的方法,减少生物样本或患者中流感病毒的数量,以及治疗患者的流感,包括向所述生物样本或患者中投与有效量的化合物,该化合物由结构式(I)表示,或其药学上可接受的盐,其中结构式(IA)的值如此处所述。其中化合物由结构式(IA)或其药学上可接受的盐表示,其中结构式(IA)的值如此处所述。药物组合物包括有效量的该化合物或其药学上可接受的盐,以及药学上可接受的载体、佐剂或载体。